MedPage Today March 12, 2025
— The erosion of trust will devastate drug trial recruitment
Can anyone trust the U.S. government when it comes to their future health? For participants in clinical trials, the answer is a hard no.
The Trump administration’s decision to end funding for the U.S. Agency for International Development (USAID) has resulted in an abrupt haltopens in a new tab or window to the clinical trials the agency funds overseas. Stopping a trial midstream violates core principles of medical ethics: It forces researchers to abandon participants — a mortal sin in medical ethics — and puts trial volunteers at considerable physical risk, a violation of the defining medical ethics requirement to “Do No Harm.”
An equally...
Today's Sponsors
Today's Sponsor